Research Summary
Recombinant human follicle-stimulating hormone (rhFSH) is a hormone produced through recombinant DNA technology, typically used in ovarian stimulation treatments during assisted reproductive technologies, such as in vitro fertilization (IVF). Follicle-stimulating hormone is a protein hormone secreted by the pituitary gland that primarily stimulates the development and maturation of ovarian follicles in females. Traditionally, follicle-stimulating hormone was extracted from urine, but recombinant technology allows for the production of pure rhFSH in the laboratory, eliminating impurities that may occur in the urine extraction process. rhFSH is clinically used to treat infertility, ovarian dysfunction, and other conditions, helping women produce multiple mature follicles and increasing the chances of pregnancy. It is also used in male treatments, particularly for low testosterone levels caused by pituitary or hypothalamic issues, to stimulate sperm production.
According to WENKH research statistics, the global Recombinant Human Follicle-stimulating Hormone market size will reach 1,337.95 Million USD in 2026 and is projected to reach 1,991.94 Million USD by 2033, with a CAGR of 5.85% (2026-2033). Among them, the Asia-Pacific Recombinant Human Follicle-stimulating Hormone market is undergoing rapid changes, reaching Million USD in 2026, accounting for approximately % of the global market share. It is projected to reach Million USD by 2033.
The global Recombinant Human Follicle-stimulating Hormone market is highly competitive, with key market players including Merck, Ferring, Livzon, Gedeon Richter, GenSci, Teva, ChangChun High & New Technology, ABL, Scripps Laboratories, Alphamab Oncology, Hunan Jingfeng Pharmaceutical, Qilu Pharmaceutical, Beijing SL Pharmaceutical, etc. This report categorizes the competitive landscape of the global Recombinant Human Follicle-stimulating Hormone market into three tiers based on annual revenue, with the top three market players holding approximately % of the total market share.
This report provides an in-depth analysis of the global Recombinant Human Follicle-stimulating Hormone market, including market size, price trends, market status and future development prospects. It particularly focuses on the market share, product characteristics, pricing, sales revenue, and gross profit margin of major players in the global Recombinant Human Follicle-stimulating Hormone industry. Additionally, this report provides an in-depth analysis of the market status and future development trends of different product segments of Recombinant Human Follicle-stimulating Hormone and their downstream application fields.
In terms of data, this report includes a comprehensive time-series dataset. The historical data spans from 2021 to 2025, providing a solid foundation for analyzing past market trends. The year 2026 is used as a base year to accurately assess the current market landscape. Forecast data covers the period from 2027 to 2033, utilizing scientific analysis methods and models to offer forward-looking predictions and insights into the market's future development. This provides valuable reference information for industry participants and stakeholders.
The report covers regions and countries including North America, Europe, China, Asia Pacific (excluding China), Latin America, the Middle East, and Africa. It particularly focuses on the sales revenue of Recombinant Human Follicle-stimulating Hormone in these regions and countries, as well as the market share of key market players in each region. The report provides an in-depth analysis of the regional distribution and future development trends of the Recombinant Human Follicle-stimulating Hormone market. By considering local policies, this report evaluates the market prospects of Recombinant Human Follicle-stimulating Hormone in each region and country, aiming to help companies gain a comprehensive understanding of the industry characteristics and development potential in different regions, optimize regional business layout, and develop precise market strategies to achieve global development goals.
This report places a strong emphasis on data quality and reliability, utilizing diverse and extensive data sources to ensure the accuracy and validity of the information presented. Primary data collection involves multiple channels, including in-depth interviews with senior executives, industry experts, supply chain stakeholders, and end consumers. These interviews provide key insights into corporate strategic planning, industry policy interpretation, supply chain dynamics, and end-user experiences. Secondary data sources cover a wide range of authoritative statistics from government agencies, customs databases, industry associations, third-party paid databases, brokerage research reports, academic research findings, corporate annual reports, financial statements, real-time news updates, and relevant information from international organizations. These data sources serve as a solid foundation for verification and analysis.
Companies Covered
Merck
Ferring
Livzon
Gedeon Richter
GenSci
Teva
ChangChun High & New Technology
ABL
Scripps Laboratories
Alphamab Oncology
Hunan Jingfeng Pharmaceutical
Qilu Pharmaceutical
Beijing SL Pharmaceutical
Product Segment
75IU
150IU
Others
Product Application
Infertility Treatment
Assisted Reproductive Technology
Chapter Scope
Chapter 1: Product Statistical Scope, Product Segmentation Types and Downstream Applications, Overall Market Size, Current Status and Development Prospects
Chapter 2: Global Recombinant Human Follicle-stimulating Hormone Industry Chain Analysis
Chapter 3: Global Recombinant Human Follicle-stimulating Hormone Industry Environment Analysis and Porter's Five Forces Analysis
Chapter 4: Analysis of the Competitive Landscape of Major Companies in the Global Recombinant Human Follicle-stimulating Hormone Market (Market Share, Product Revenue Comparison, Tier Division, Corporate Expansion and M&A Trends)
Chapter 5: Analysis of Global Major Companies (Company Profiles, Product Features and Product Segment, Product Revenue, Product Average Price, Gross Profit Margin and Geographical Sales Share)
Chapter 6: Global Recombinant Human Follicle-stimulating Hormone Product Segment and Downstream Application Size Analysis and Major Regional Market Size Analysis
Chapter 7: North America Recombinant Human Follicle-stimulating Hormone Product Segment, Downstream Application, and Major Countries Market Size Analysis
Chapter 8: Europe Recombinant Human Follicle-stimulating Hormone Product Segment, Downstream Application, and Major Countries Market Size Analysis
Chapter 9: China Recombinant Human Follicle-stimulating Hormone Product Segment, Downstream Application, and Major Countries Market Size Analysis
Chapter 10: Asia Pacific (excluding China) Recombinant Human Follicle-stimulating Hormone Product Segment, Downstream Application, and Major Countries Market Size Analysis
Chapter 11: Latin America Recombinant Human Follicle-stimulating Hormone Product Segment, Downstream Application, and Major Countries Market Size Analysis
Chapter 12: Middle East and Africa Recombinant Human Follicle-stimulating Hormone Product Segment, Downstream Application, and Major Countries Market Size Analysis
Chapter 13: Research Conclusion
Chapter 14: Methodology and Data Source
Purpose and Value of the Report
Market Trend Insights: Analyze industry trends, market dynamics, and future growth potential to help companies forecast changes and develop strategic plans.
Competitive Landscape Analysis: Understand key players' revenue segmentation, strategies, market share, and business models to guide competitive decisions.
Investment Decision Support: Provide feasibility analysis through market size, growth rate, demand trends, and potential risks for informed investment decisions.
Target Customer and Demand Analysis: Examine consumer behavior, purchasing preferences, and pain points to optimize products and improve market penetration.
Policy and Regulatory Insights: Interpret relevant industry policies to ensure compliance and mitigate regulatory risks.
Business Model Optimization: Offer data-driven suggestions for enhancing business models and improving profitability.
Table of Contents
1 Recombinant Human Follicle-stimulating Hormone Market Overview
1.1 Product Definition Introduction
1.2 Global Recombinant Human Follicle-stimulating Hormone Market Size and Growth Forecast Analysis (2021-2033)
1.3 Recombinant Human Follicle-stimulating Hormone Market Status and Development Prospects
1.3.1 Recombinant Human Follicle-stimulating Hormone Market Status
1.3.2 Recombinant Human Follicle-stimulating Hormone Industry Development Prospects
1.4 Recombinant Human Follicle-stimulating Hormone Market Overview by Product Segment
1.4.1 Global Recombinant Human Follicle-stimulating Hormone Market Size and Growth Forecast Analysis by Product Segment: 2021 VS 2026 VS 2033
1.4.2 75IU
1.4.3 150IU
1.4.4 Others
1.5 Recombinant Human Follicle-stimulating Hormone Market Overview by Product Application
1.5.1 Global Recombinant Human Follicle-stimulating Hormone Market Size and Growth Forecast Analysis by Product Application: 2021 VS 2026 VS 2033
1.5.2 Infertility Treatment
1.5.3 Assisted Reproductive Technology
2 Recombinant Human Follicle-stimulating Hormone Industry Supply Chain Analysis
2.1 Recombinant Human Follicle-stimulating Hormone Supply Chain
2.2 Recombinant Human Follicle-stimulating Hormone Midstream Suppliers
2.3 Recombinant Human Follicle-stimulating Hormone Downstream Customers
2.4 Recombinant Human Follicle-stimulating Hormone Sales Channel Analysis
3 Recombinant Human Follicle-stimulating Hormone Market Environment Analysis
3.1 Recombinant Human Follicle-stimulating Hormone Industry Policy Analysis
3.2 Recombinant Human Follicle-stimulating Hormone Emerging Technology Trends in the Industry
3.3 Recombinant Human Follicle-stimulating Hormone Restraining Factors Analysis
3.4 Recombinant Human Follicle-stimulating Hormone Market Porter's Five Forces Analysis
3.4.1 Competitive Rivalry
3.4.2 Threat of New Entrants
3.4.3 Bargaining Power of Suppliers
3.4.4 Bargaining Power of Buyers
3.4.5 Threat of Substitute Products or Services
4 Global Recombinant Human Follicle-stimulating Hormone Market Players Competition Landscape
4.1 Global Recombinant Human Follicle-stimulating Hormone Market Revenue by Key Players (2021-2026)
4.2 Global Recombinant Human Follicle-stimulating Hormone Market Position by Key Players
4.3 Global Key Players Headquarter and Key Area Served
4.4 Global Recombinant Human Follicle-stimulating Hormone Market Expansion and M&A Dynamic
5 In-depth Analysis of Key Players
5.1 Merck
5.1.1 Merck Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
5.1.2 Merck Recombinant Human Follicle-stimulating Hormone Product Features
5.1.3 Merck Recombinant Human Follicle-stimulating Hormone Product Revenue and Gross Margin Analysis (2021-2026)
5.1.4 Merck Recombinant Human Follicle-stimulating Hormone Revenue by Product Segment
5.1.5 Merck Recombinant Human Follicle-stimulating Hormone Revenue by Region
5.2 Ferring
5.2.1 Ferring Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
5.2.2 Ferring Recombinant Human Follicle-stimulating Hormone Product Features
5.2.3 Ferring Recombinant Human Follicle-stimulating Hormone Product Revenue and Gross Margin Analysis (2021-2026)
5.2.4 Ferring Recombinant Human Follicle-stimulating Hormone Revenue by Product Segment
5.2.5 Ferring Recombinant Human Follicle-stimulating Hormone Revenue by Region
5.3 Livzon
5.3.1 Livzon Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
5.3.2 Livzon Recombinant Human Follicle-stimulating Hormone Product Features
5.3.3 Livzon Recombinant Human Follicle-stimulating Hormone Product Revenue and Gross Margin Analysis (2021-2026)
5.3.4 Livzon Recombinant Human Follicle-stimulating Hormone Revenue by Product Segment
5.3.5 Livzon Recombinant Human Follicle-stimulating Hormone Revenue by Region
5.4 Gedeon Richter
5.4.1 Gedeon Richter Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
5.4.2 Gedeon Richter Recombinant Human Follicle-stimulating Hormone Product Features
5.4.3 Gedeon Richter Recombinant Human Follicle-stimulating Hormone Product Revenue and Gross Margin Analysis (2021-2026)
5.4.4 Gedeon Richter Recombinant Human Follicle-stimulating Hormone Revenue by Product Segment
5.4.5 Gedeon Richter Recombinant Human Follicle-stimulating Hormone Revenue by Region
5.5 GenSci
5.5.1 GenSci Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
5.5.2 GenSci Recombinant Human Follicle-stimulating Hormone Product Features
5.5.3 GenSci Recombinant Human Follicle-stimulating Hormone Product Revenue and Gross Margin Analysis (2021-2026)
5.5.4 GenSci Recombinant Human Follicle-stimulating Hormone Revenue by Product Segment
5.5.5 GenSci Recombinant Human Follicle-stimulating Hormone Revenue by Region
5.6 Teva
5.6.1 Teva Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
5.6.2 Teva Recombinant Human Follicle-stimulating Hormone Product Features
5.6.3 Teva Recombinant Human Follicle-stimulating Hormone Product Revenue and Gross Margin Analysis (2021-2026)
5.6.4 Teva Recombinant Human Follicle-stimulating Hormone Revenue by Product Segment
5.6.5 Teva Recombinant Human Follicle-stimulating Hormone Revenue by Region
5.7 ChangChun High & New Technology
5.7.1 ChangChun High & New Technology Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
5.7.2 ChangChun High & New Technology Recombinant Human Follicle-stimulating Hormone Product Features
5.7.3 ChangChun High & New Technology Recombinant Human Follicle-stimulating Hormone Product Revenue and Gross Margin Analysis (2021-2026)
5.7.4 ChangChun High & New Technology Recombinant Human Follicle-stimulating Hormone Revenue by Product Segment
5.7.5 ChangChun High & New Technology Recombinant Human Follicle-stimulating Hormone Revenue by Region
5.8 ABL
5.8.1 ABL Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
5.8.2 ABL Recombinant Human Follicle-stimulating Hormone Product Features
5.8.3 ABL Recombinant Human Follicle-stimulating Hormone Product Revenue and Gross Margin Analysis (2021-2026)
5.8.4 ABL Recombinant Human Follicle-stimulating Hormone Revenue by Product Segment
5.8.5 ABL Recombinant Human Follicle-stimulating Hormone Revenue by Region
5.9 Scripps Laboratories
5.9.1 Scripps Laboratories Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
5.9.2 Scripps Laboratories Recombinant Human Follicle-stimulating Hormone Product Features
5.9.3 Scripps Laboratories Recombinant Human Follicle-stimulating Hormone Product Revenue and Gross Margin Analysis (2021-2026)
5.9.4 Scripps Laboratories Recombinant Human Follicle-stimulating Hormone Revenue by Product Segment
5.9.5 Scripps Laboratories Recombinant Human Follicle-stimulating Hormone Revenue by Region
5.10 Alphamab Oncology
5.10.1 Alphamab Oncology Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
5.10.2 Alphamab Oncology Recombinant Human Follicle-stimulating Hormone Product Features
5.10.3 Alphamab Oncology Recombinant Human Follicle-stimulating Hormone Product Revenue and Gross Margin Analysis (2021-2026)
5.10.4 Alphamab Oncology Recombinant Human Follicle-stimulating Hormone Revenue by Product Segment
5.10.5 Alphamab Oncology Recombinant Human Follicle-stimulating Hormone Revenue by Region
5.11 Hunan Jingfeng Pharmaceutical
5.11.1 Hunan Jingfeng Pharmaceutical Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
5.11.2 Hunan Jingfeng Pharmaceutical Recombinant Human Follicle-stimulating Hormone Product Features
5.11.3 Hunan Jingfeng Pharmaceutical Recombinant Human Follicle-stimulating Hormone Product Revenue and Gross Margin Analysis (2021-2026)
5.11.4 Hunan Jingfeng Pharmaceutical Recombinant Human Follicle-stimulating Hormone Revenue by Product Segment
5.11.5 Hunan Jingfeng Pharmaceutical Recombinant Human Follicle-stimulating Hormone Revenue by Region
5.12 Qilu Pharmaceutical
5.12.1 Qilu Pharmaceutical Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
5.12.2 Qilu Pharmaceutical Recombinant Human Follicle-stimulating Hormone Product Features
5.12.3 Qilu Pharmaceutical Recombinant Human Follicle-stimulating Hormone Product Revenue and Gross Margin Analysis (2021-2026)
5.12.4 Qilu Pharmaceutical Recombinant Human Follicle-stimulating Hormone Revenue by Product Segment
5.12.5 Qilu Pharmaceutical Recombinant Human Follicle-stimulating Hormone Revenue by Region
5.13 Beijing SL Pharmaceutical
5.13.1 Beijing SL Pharmaceutical Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
5.13.2 Beijing SL Pharmaceutical Recombinant Human Follicle-stimulating Hormone Product Features
5.13.3 Beijing SL Pharmaceutical Recombinant Human Follicle-stimulating Hormone Product Revenue and Gross Margin Analysis (2021-2026)
5.13.4 Beijing SL Pharmaceutical Recombinant Human Follicle-stimulating Hormone Revenue by Product Segment
5.13.5 Beijing SL Pharmaceutical Recombinant Human Follicle-stimulating Hormone Revenue by Region
6 Global Recombinant Human Follicle-stimulating Hormone Market Analysis by Regions, by Product Segment and Application
6.1 Global Recombinant Human Follicle-stimulating Hormone Market Size and Growth Forecast by Region: 2021 VS 2026 VS 2033
6.1.1 Global Recombinant Human Follicle-stimulating Hormone Market Revenue by Region (2021-2026)
6.1.2 Global Recombinant Human Follicle-stimulating Hormone Market Revenue Forecast by Region (2027-2033)
6.2 Global Recombinant Human Follicle-stimulating Hormone Market Size by Product Segment (2021-2033)
6.3 Global Recombinant Human Follicle-stimulating Hormone Market Size by Product Application (2021-2033)
7 North America Recombinant Human Follicle-stimulating Hormone Market Analysis
7.1 North America Recombinant Human Follicle-stimulating Hormone Market Prospects
7.1.1 North America Recombinant Human Follicle-stimulating Hormone Market Revenue and Growth Forecast by Countries (2021-2033)
7.1.2 U.S.
7.1.3 Canada
7.2 North America Recombinant Human Follicle-stimulating Hormone Market Size by Product Segment (2021-2033)
7.3 North America Recombinant Human Follicle-stimulating Hormone Market Size by Product Application (2021-2033)
8 Europe Recombinant Human Follicle-stimulating Hormone Market Analysis
8.1 Europe Recombinant Human Follicle-stimulating Hormone Market Prospects
8.1.1 Europe Recombinant Human Follicle-stimulating Hormone Market Revenue and Growth Forecast by Countries (2021-2033)
8.1.2 Germany
8.1.3 France
8.1.4 United Kingdom
8.1.5 Italy
8.1.6 Spain
8.1.7 Benelux
8.2 Europe Recombinant Human Follicle-stimulating Hormone Market Size by Product Segment (2021-2033)
8.3 Europe Recombinant Human Follicle-stimulating Hormone Market Size by Product Application (2021-2033)
9 China Recombinant Human Follicle-stimulating Hormone Market Analysis
9.1 China Recombinant Human Follicle-stimulating Hormone Market Prospects
9.2 China Recombinant Human Follicle-stimulating Hormone Market Size by Product Segment (2021-2033)
9.3 China Recombinant Human Follicle-stimulating Hormone Market Size by Product Application (2021-2033)
10 Asia Pacific (excl. China) Recombinant Human Follicle-stimulating Hormone Market Analysis
10.1 Asia Pacific (excl. China) Recombinant Human Follicle-stimulating Hormone Market Prospects
10.1.1 Asia Pacific (excl. China) Recombinant Human Follicle-stimulating Hormone Revenue and Growth Forecast by Countries (2021-2033)
10.1.2 Japan
10.1.3 South Korea
10.1.4 India
10.1.5 Southeast Asia
10.1.6 Australia
10.2 Asia Pacific (excl. China) Recombinant Human Follicle-stimulating Hormone Market Size by Product Segment (2021-2033)
10.3 Asia Pacific (excl. China) Recombinant Human Follicle-stimulating Hormone Market Size by Product Application (2021-2033)
11 Latin America Recombinant Human Follicle-stimulating Hormone Market Analysis
11.1 Latin America Recombinant Human Follicle-stimulating Hormone Market Prospects
11.1.1 Latin America Recombinant Human Follicle-stimulating Hormone Revenue and Growth Forecast by Countries (2021-2033)
11.1.2 Mexico
11.1.3 Brazil
11.2 Latin America Recombinant Human Follicle-stimulating Hormone Market Size by Product Segment (2021-2033)
11.3 Latin America Recombinant Human Follicle-stimulating Hormone Market Size by Product Application (2021-2033)
12 Middle East and Africa Recombinant Human Follicle-stimulating Hormone Market Analysis
12.1 Middle East and Africa Recombinant Human Follicle-stimulating Hormone Market Prospects
12.1.1 Middle East and Africa Recombinant Human Follicle-stimulating Hormone Revenue and Growth Forecast by Countries (2021-2033)
12.1.2 Saudi Arabia
12.1.3 South Africa
12.2 Middle East and Africa Recombinant Human Follicle-stimulating Hormone Market Size by Product Segment (2021-2033)
12.3 Middle East and Africa Recombinant Human Follicle-stimulating Hormone Market Size by Product Application (2021-2033)
13 Research Conclusion
14 Appendix
14.1 Methodology/Research Approach
14.2 Research Landscape
14.3 Research Benchmark and Hypothesis
14.4 Data Source
14.4.1 Primary Sources
14.4.2 Secondary Sources
14.5 Data Cross Validation
14.6 Disclaimer
Table 1：Global Recombinant Human Follicle-stimulating Hormone Market Size and Growth Forecast Analysis by Product Segment (2021 VS 2026 VS 2033) & (Million USD)
Table 2：Global Recombinant Human Follicle-stimulating Hormone Market Size and Growth Forecast Analysis by Product Application (2021 VS 2026 VS 2033) & (Million USD)
Table 3：Recombinant Human Follicle-stimulating Hormone Downstream Customers List
Table 4：Recombinant Human Follicle-stimulating Hormone Distributors/Dealers List
Table 5：Global Recombinant Human Follicle-stimulating Hormone Market Revenue by Key Players (2021-2026) & (Million USD)
Table 6：Global Recombinant Human Follicle-stimulating Hormone Market Position by Key Players
Table 7：Global Key Players Headquarter and Key Area Served
Table 8：Global Recombinant Human Follicle-stimulating Hormone Market Expansion and M&A Dynamic
Table 9：Merck Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
Table 10：Merck Recombinant Human Follicle-stimulating Hormone Product Features
Table 11：Merck Recombinant Human Follicle-stimulating Hormone Revenue (Million USD) and Gross Margin (2021-2026)
Table 12：Merck Recombinant Human Follicle-stimulating Hormone Revenue by Product Segment
Table 13：Merck Recombinant Human Follicle-stimulating Hormone Revenue by Region
Table 14：Ferring Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
Table 15：Ferring Recombinant Human Follicle-stimulating Hormone Product Features
Table 16：Ferring Recombinant Human Follicle-stimulating Hormone Revenue (Million USD) and Gross Margin (2021-2026)
Table 17：Ferring Recombinant Human Follicle-stimulating Hormone Revenue by Product Segment
Table 18：Ferring Recombinant Human Follicle-stimulating Hormone Revenue by Region
Table 19：Livzon Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
Table 20：Livzon Recombinant Human Follicle-stimulating Hormone Product Features
Table 21：Livzon Recombinant Human Follicle-stimulating Hormone Revenue (Million USD) and Gross Margin (2021-2026)
Table 22：Livzon Recombinant Human Follicle-stimulating Hormone Revenue by Product Segment
Table 23：Livzon Recombinant Human Follicle-stimulating Hormone Revenue by Region
Table 24：Gedeon Richter Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
Table 25：Gedeon Richter Recombinant Human Follicle-stimulating Hormone Product Features
Table 26：Gedeon Richter Recombinant Human Follicle-stimulating Hormone Revenue (Million USD) and Gross Margin (2021-2026)
Table 27：Gedeon Richter Recombinant Human Follicle-stimulating Hormone Revenue by Product Segment
Table 28：Gedeon Richter Recombinant Human Follicle-stimulating Hormone Revenue by Region
Table 29：GenSci Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
Table 30：GenSci Recombinant Human Follicle-stimulating Hormone Product Features
Table 31：GenSci Recombinant Human Follicle-stimulating Hormone Revenue (Million USD) and Gross Margin (2021-2026)
Table 32：GenSci Recombinant Human Follicle-stimulating Hormone Revenue by Product Segment
Table 33：GenSci Recombinant Human Follicle-stimulating Hormone Revenue by Region
Table 34：Teva Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
Table 35：Teva Recombinant Human Follicle-stimulating Hormone Product Features
Table 36：Teva Recombinant Human Follicle-stimulating Hormone Revenue (Million USD) and Gross Margin (2021-2026)
Table 37：Teva Recombinant Human Follicle-stimulating Hormone Revenue by Product Segment
Table 38：Teva Recombinant Human Follicle-stimulating Hormone Revenue by Region
Table 39：ChangChun High & New Technology Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
Table 40：ChangChun High & New Technology Recombinant Human Follicle-stimulating Hormone Product Features
Table 41：ChangChun High & New Technology Recombinant Human Follicle-stimulating Hormone Revenue (Million USD) and Gross Margin (2021-2026)
Table 42：ChangChun High & New Technology Recombinant Human Follicle-stimulating Hormone Revenue by Product Segment
Table 43：ChangChun High & New Technology Recombinant Human Follicle-stimulating Hormone Revenue by Region
Table 44：ABL Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
Table 45：ABL Recombinant Human Follicle-stimulating Hormone Product Features
Table 46：ABL Recombinant Human Follicle-stimulating Hormone Revenue (Million USD) and Gross Margin (2021-2026)
Table 47：ABL Recombinant Human Follicle-stimulating Hormone Revenue by Product Segment
Table 48：ABL Recombinant Human Follicle-stimulating Hormone Revenue by Region
Table 49：Scripps Laboratories Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
Table 50：Scripps Laboratories Recombinant Human Follicle-stimulating Hormone Product Features
Table 51：Scripps Laboratories Recombinant Human Follicle-stimulating Hormone Revenue (Million USD) and Gross Margin (2021-2026)
Table 52：Scripps Laboratories Recombinant Human Follicle-stimulating Hormone Revenue by Product Segment
Table 53：Scripps Laboratories Recombinant Human Follicle-stimulating Hormone Revenue by Region
Table 54：Alphamab Oncology Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
Table 55：Alphamab Oncology Recombinant Human Follicle-stimulating Hormone Product Features
Table 56：Alphamab Oncology Recombinant Human Follicle-stimulating Hormone Revenue (Million USD) and Gross Margin (2021-2026)
Table 57：Alphamab Oncology Recombinant Human Follicle-stimulating Hormone Revenue by Product Segment
Table 58：Alphamab Oncology Recombinant Human Follicle-stimulating Hormone Revenue by Region
Table 59：Hunan Jingfeng Pharmaceutical Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
Table 60：Hunan Jingfeng Pharmaceutical Recombinant Human Follicle-stimulating Hormone Product Features
Table 61：Hunan Jingfeng Pharmaceutical Recombinant Human Follicle-stimulating Hormone Revenue (Million USD) and Gross Margin (2021-2026)
Table 62：Hunan Jingfeng Pharmaceutical Recombinant Human Follicle-stimulating Hormone Revenue by Product Segment
Table 63：Hunan Jingfeng Pharmaceutical Recombinant Human Follicle-stimulating Hormone Revenue by Region
Table 64：Qilu Pharmaceutical Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
Table 65：Qilu Pharmaceutical Recombinant Human Follicle-stimulating Hormone Product Features
Table 66：Qilu Pharmaceutical Recombinant Human Follicle-stimulating Hormone Revenue (Million USD) and Gross Margin (2021-2026)
Table 67：Qilu Pharmaceutical Recombinant Human Follicle-stimulating Hormone Revenue by Product Segment
Table 68：Qilu Pharmaceutical Recombinant Human Follicle-stimulating Hormone Revenue by Region
Table 69：Beijing SL Pharmaceutical Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
Table 70：Beijing SL Pharmaceutical Recombinant Human Follicle-stimulating Hormone Product Features
Table 71：Beijing SL Pharmaceutical Recombinant Human Follicle-stimulating Hormone Revenue (Million USD) and Gross Margin (2021-2026)
Table 72：Beijing SL Pharmaceutical Recombinant Human Follicle-stimulating Hormone Revenue by Product Segment
Table 73：Beijing SL Pharmaceutical Recombinant Human Follicle-stimulating Hormone Revenue by Region
Table 74：Global Recombinant Human Follicle-stimulating Hormone Market Size and Growth Forecast by Region (2021 VS 2026 VS 2033) & (Million USD)
Table 75：Global Recombinant Human Follicle-stimulating Hormone Market Revenue by Region (2021-2026) & (Million USD)
Table 76：Global Recombinant Human Follicle-stimulating Hormone Market Share by Region (2021-2026)
Table 77：Global Recombinant Human Follicle-stimulating Hormone Market Revenue Forecast by Region (2027-2033) & (Million USD)
Table 78：Global Recombinant Human Follicle-stimulating Hormone Market Share Forecast by Region (2027-2033)
Table 79：Global Recombinant Human Follicle-stimulating Hormone Market Revenue by Product Segment (2021-2026) & (Million USD)
Table 80：Global Recombinant Human Follicle-stimulating Hormone Market Revenue Forecast by Product Segment (2027-2033) & (Million USD)
Table 81：Global Recombinant Human Follicle-stimulating Hormone Market Revenue by Product Application (2021-2026) & (Million USD)
Table 82：Global Recombinant Human Follicle-stimulating Hormone Market Revenue Forecast by Product Application (2027-2033) & (Million USD)
Table 83：North America Recombinant Human Follicle-stimulating Hormone Market Revenue by Countries (2021-2026) & (Million USD)
Table 84：North AmericaRecombinant Human Follicle-stimulating Hormone Market Revenue Forecast by Countries (2027-2033) & (Million USD)
Table 85：North America Recombinant Human Follicle-stimulating Hormone Market Revenue by Product Segment (2021-2026) & (Million USD)
Table 86：North America Recombinant Human Follicle-stimulating Hormone Market Revenue Forecast by Product Segment (2027-2033) & (Million USD)
Table 87：North America Recombinant Human Follicle-stimulating Hormone Market Revenue by Product Application (2021-2026) & (Million USD)
Table 88：North America Recombinant Human Follicle-stimulating Hormone Market Revenue Forecast by Product Application (2027-2033) & (Million USD)
Table 89：Europe Recombinant Human Follicle-stimulating Hormone Market Revenue by Countries (2021-2026) & (Million USD)
Table 90：Europe Recombinant Human Follicle-stimulating Hormone Market Revenue Forecast by Countries (2027-2033) & (Million USD)
Table 91：Europe Recombinant Human Follicle-stimulating Hormone Market Revenue by Product Segment (2021-2026) & (Million USD)
Table 92：Europe Recombinant Human Follicle-stimulating Hormone Market Revenue Forecast by Product Segment (2027-2033) & (Million USD)
Table 93：Europe Recombinant Human Follicle-stimulating Hormone Market Revenue by Product Application (2021-2026) & (Million USD)
Table 94：Europe Recombinant Human Follicle-stimulating Hormone Market Revenue Forecast by Product Application (2027-2033) & (Million USD)
Table 95：China Recombinant Human Follicle-stimulating Hormone Market Revenue by Product Segment (2021-2026) & (Million USD)
Table 96：China Recombinant Human Follicle-stimulating Hormone Market Revenue Forecast by Product Segment (2027-2033) & (Million USD)
Table 97：China Recombinant Human Follicle-stimulating Hormone Market Revenue by Product Application (2021-2026) & (Million USD)
Table 98：China Recombinant Human Follicle-stimulating Hormone Market Revenue Forecast by Product Application (2027-2033) & (Million USD)
Table 99：Asia Pacific (excl. China) Recombinant Human Follicle-stimulating Hormone Market Revenue by Countries (2021-2026) & (Million USD)
Table 100：Asia Pacific (excl. China) Recombinant Human Follicle-stimulating Hormone Market Revenue Forecast by Countries (2027-2033) & (Million USD)
Table 101：Asia Pacific (excl. China) Recombinant Human Follicle-stimulating Hormone Market Revenue by Product Segment (2021-2026) & (Million USD)
Table 102：Asia Pacific (excl. China) Recombinant Human Follicle-stimulating Hormone Market Revenue Forecast by Product Segment (2027-2033) & (Million USD)
Table 103：Asia Pacific (excl. China) Recombinant Human Follicle-stimulating Hormone Market Revenue by Product Application (2021-2026) & (Million USD)
Table 104：Asia Pacific (excl. China) Recombinant Human Follicle-stimulating Hormone Market Revenue Forecast by Product Application (2027-2033) & (Million USD)
Table 105：Latin America Recombinant Human Follicle-stimulating Hormone Market Revenue by Countries (2021-2026) & (Million USD)
Table 106：Latin America Recombinant Human Follicle-stimulating Hormone Market Revenue Forecast by Countries (2027-2033) & (Million USD)
Table 107：Latin America Recombinant Human Follicle-stimulating Hormone Market Revenue by Product Segment (2021-2026) & (Million USD)
Table 108：Latin America Recombinant Human Follicle-stimulating Hormone Market Revenue Forecast by Product Segment (2027-2033) & (Million USD)
Table 109：Latin America Recombinant Human Follicle-stimulating Hormone Market Revenue by Product Application (2021-2026) & (Million USD)
Table 110：Latin America Recombinant Human Follicle-stimulating Hormone Market Revenue Forecast by Product Application (2027-2033) & (Million USD)
Table 111：Middle East and Africa Recombinant Human Follicle-stimulating Hormone Market Revenue by Countries (2021-2026) & (Million USD)
Table 112：Middle East and Africa Recombinant Human Follicle-stimulating Hormone Market Revenue Forecast by Countries (2027-2033) & (Million USD)
Table 113：Middle East and Africa Recombinant Human Follicle-stimulating Hormone Market Revenue by Product Segment (2021-2026) & (Million USD)
Table 114：Middle East and Africa Recombinant Human Follicle-stimulating Hormone Market Revenue Forecast by Product Segment (2027-2033) & (Million USD)
Table 115：Middle East and Africa Recombinant Human Follicle-stimulating Hormone Market Revenue by Product Application (2021-2026) & (Million USD)
Table 116：Middle East and Africa Recombinant Human Follicle-stimulating Hormone Market Revenue Forecast by Product Application (2027-2033) & (Million USD)
Table 117：Secondary Sources
Figure 1：Recombinant Human Follicle-stimulating Hormone Product Scope
Figure 2：Global Recombinant Human Follicle-stimulating Hormone Market Size and Growth Forecast Analysis (2021-2033) & (Million USD)
Figure 3：Global Recombinant Human Follicle-stimulating Hormone Product Segment Market Share (2026 & 2033)
Figure 4：Global Recombinant Human Follicle-stimulating Hormone Product Application Market Share (2026 & 2033)
Figure 5：75IU Product Scope
Figure 6：150IU Product Scope
Figure 7：Others Product Scope
Figure 8：Infertility Treatment Product Scope
Figure 9：Assisted Reproductive Technology Product Scope
Figure 10：Recombinant Human Follicle-stimulating Hormone Industrial Chain Framework
Figure 11：Global Recombinant Human Follicle-stimulating Hormone Market by Geographic Segmentation in 2026
Figure 12：Global Recombinant Human Follicle-stimulating Hormone Market Share by Region (2021 VS 2026)
Figure 13：North America Recombinant Human Follicle-stimulating Hormone Market Size and Growth Forecast (2025 VS 2026 VS 2033) & (Million USD)
Figure 14：North America Recombinant Human Follicle-stimulating Hormone Revenue Market Share by Countries (2026 VS 2033)
Figure 15：U.S. Recombinant Human Follicle-stimulating Hormone Market Revenue and Forecast (2021-2033) & (Million USD)
Figure 16：Canada Recombinant Human Follicle-stimulating Hormone Market Revenue and Forecast (2021-2033) & (Million USD)
Figure 17：Europe Recombinant Human Follicle-stimulating Hormone Market Size and Growth Forecast (2025 VS 2026 VS 2033) & (Million USD)
Figure 18：Europe Recombinant Human Follicle-stimulating Hormone Revenue Market Share by Countries (2026 VS 2033)
Figure 19：Germany Recombinant Human Follicle-stimulating Hormone Market Revenue and Forecast (2021-2033) & (Million USD)
Figure 20：France Recombinant Human Follicle-stimulating Hormone Market Revenue and Forecast (2021-2033) & (Million USD)
Figure 21：United Kingdom Recombinant Human Follicle-stimulating Hormone Market Revenue and Forecast (2021-2033) & (Million USD)
Figure 22：Italy Recombinant Human Follicle-stimulating Hormone Market Revenue and Forecast (2021-2033) & (Million USD)
Figure 23：Spain Recombinant Human Follicle-stimulating Hormone Market Revenue and Forecast (2021-2033) & (Million USD)
Figure 24：Benelux Recombinant Human Follicle-stimulating Hormone Market Revenue and Forecast (2021-2033) & (Million USD)
Figure 25：China Recombinant Human Follicle-stimulating Hormone Market Size and Growth Forecast (2025 VS 2026 VS 2033) & (Million USD)
Figure 26：Asia Pacific (excl. China) Recombinant Human Follicle-stimulating Hormone Market Size and Growth Forecast (2025 VS 2026 VS 2033) & (Million USD)
Figure 27：Asia Pacific (excl. China) Recombinant Human Follicle-stimulating Hormone Revenue Market Share by Countries (2026 VS 2033)
Figure 28：Japan Recombinant Human Follicle-stimulating Hormone Market Revenue and Forecast (2021-2033) & (Million USD)
Figure 29：South Korea Recombinant Human Follicle-stimulating Hormone Market Revenue and Forecast (2021-2033) & (Million USD)
Figure 30：India Recombinant Human Follicle-stimulating Hormone Market Revenue and Forecast (2021-2033) & (Million USD)
Figure 31：Southeast Asia Recombinant Human Follicle-stimulating Hormone Market Revenue and Forecast (2021-2033) & (Million USD)
Figure 32：Australia Recombinant Human Follicle-stimulating Hormone Market Revenue and Forecast (2021-2033) & (Million USD)
Figure 33：Latin America Recombinant Human Follicle-stimulating Hormone Market Size and Growth Forecast (2025 VS 2026 VS 2033) & (Million USD)
Figure 34：Latin America Recombinant Human Follicle-stimulating Hormone Revenue Market Share by Countries (2026 VS 2033)
Figure 35：Mexico Recombinant Human Follicle-stimulating Hormone Market Revenue and Forecast (2021-2033) & (Million USD)
Figure 36：Brazil Recombinant Human Follicle-stimulating Hormone Market Revenue and Forecast (2021-2033) & (Million USD)
Figure 37：Middle East and Africa Recombinant Human Follicle-stimulating Hormone Market Size and Growth Forecast (2025 VS 2026 VS 2033) & (Million USD)
Figure 38：Middle East and Africa Recombinant Human Follicle-stimulating Hormone Revenue Market Share by Countries (2026 VS 2033)
Figure 39：Saudi Arabia Recombinant Human Follicle-stimulating Hormone Market Revenue and Forecast (2021-2033) & (Million USD)
Figure 40：South Africa Recombinant Human Follicle-stimulating Hormone Market Revenue and Forecast (2021-2033) & (Million USD)
Figure 41：Research Methodology
Figure 42：Primary Sources
Figure 43：Data Cross Validation
English
Related Reports 
